Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +9108048034981 (International callers) or 08048034981 (Indian callers).
Entaliv 0.5 Tablet is an antiviral medication prescribed to treat chronic Hepatitis B virus (HBV) infection in adults and children. It contains Entecavir as its active ingredient and works by inhibiting the virus's ability to multiply in the liver cells, though it is not a complete cure.
Category: Antiviral Agent / Nucleoside Analog
Reviro 300 is an antiviral prescription medication containing Tenofovir Disoproxil Fumarate (300mg). It is primarily used to treat chronic Hepatitis B virus (HBV) infection and manage HIV-1 infection in combination with other antiretroviral drugs.
Velakast 400/100 is a generic antiviral medication combining Sofosbuvir (400 mg) and Velpatasvir (100 mg). It is widely prescribed to treat chronic Hepatitis C virus (HCV) infections across genotypes 1 through 6 .
MyHep LVIR is a prescription antiviral medication manufactured by Mylan (now Viatris) designed to cure chronic Hepatitis C Virus (HCV) infections in adults and children over the age of three .
MyHep 400 mg (manufactured by Mylan) is a prescription antiviral medication containing Sofosbuvir. It is primarily used in combination regimens (such as with ribavirin, daclatasvir, or velpatasvir) to treat chronic Hepatitis C (HCV) infection by preventing the virus from multiplying.
Hepcinat LP is an antiviral prescription medication manufactured by Natco Pharma for the treatment of chronic Hepatitis C Virus (HCV) infection in adults.
The combination of Ledipasvir and Sofosbuvir disrupts the replication process of the Hepatitis C virus. Ledipasvir targets the viral NS5A protein, while Sofosbuvir inhibits the NS5B RNA polymerase enzyme. Together, they significantly lower the viral load in the blood and prevent the virus from multiplying, which can help clear the infection and prevent liver damage.
Trustiva tablet is a prescription, fixed-dose antiretroviral medicine for the treatment of HIV-1 infection in adults and adolescents. It combines three active antiviral ingredients into a single, once-daily tablet intended to suppress viral replication, boost immunity, and prevent the progression of HIV-1.
Tenof 300mg Tablet is a prescription antiviral medication , primarily used to treat chronic Hepatitis B virus (HBV) and HIV-1 infections. It works by inhibiting reverse transcriptase, a key enzyme responsible for viral replication
A-Bec 300 mg Tablet an antiretroviral medication containing Abacavir (300mg), primarily used to treat HIV-1 infection in adults and children (weighing >25 kg). It works by inhibiting the reverse transcriptase enzyme, crucial for HIV replication, thereby reducing the viral load and increasing CD4 cell counts to enhance immune function.
Lamivir HBV 100 mg (Lamivudine) is a prescription antiviral medication from Cipla used primarily to treat chronic Hepatitis B (HBV) and HIV-1 by inhibiting viral replication. It acts as a nucleoside reverse transcriptase inhibitor (NRTI), generally taken daily, and is crucial for reducing viral load to prevent liver damage and HIV complications.
Tenolam E tablet is a combination antiretroviral medication manufactured by Hetero Drugs Ltd., used to treat HIV-1 infection in adults and adolescents (typically weighing 35-40 kg or more). It acts by inhibiting the reproduction of the virus and boosting immunity, usually as part of combination therapy, though it is not a cure for HIV or AIDS.
Trioday tablet is antiretroviral medication primarily used to manage HIV-1 infections in adults and adolescents weighing 35 kg or more. It is a fixed-dose combination of three active ingredients: Efavirenz (600mg or 400mg), Lamivudine (300mg), and Tenofovir Disoproxil Fumarate (300mg).
Trioday works by combining two nucleoside reverse transcriptase inhibitors (NRTIs)—Lamivudine and Tenofovir—with a non-nucleoside reverse transcriptase inhibitor (NNRTI), Efavirenz. This triple-action formula inhibits the reverse transcriptase enzyme, which is necessary for the HIV virus to replicate its genetic material, thereby reducing the amount of virus in the body (viral load) and strengthening the immune system.
Xapavir is an antiretroviral medication used to treat HIV-1 infection, typically available in two main forms: Xapavir 50 (Dolutegravir) and Xapavir LT (Dolutegravir + Lamivudine + Tenofovir). It acts by reducing the viral load and increasing CD4 cell counts to manage HIV and prevent it from progressing to AIDS.
Viraday tablets are primarily tagged as an antiretroviral medication used in the treatment and management of HIV-1 infection. Manufactured by Cipla Ltd., this combination drug is categorized under Anti-HIV medicines and is designed for once-a-day oral administration.
Spegra tablet is a fixed-dose combination antiretroviral medication manufactured by Emcure Pharmaceuticals Ltd, designed to treat HIV-1 infection in adults and adolescents (weighing at least 35-40kg). It combines three active ingredients—Dolutegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg)—into a single, once-daily tablet, enhancing adherence and reducing pill burden.
Lazid N Tablet is an antiretroviral medication used to treat HIV-1 infection in adults and children over 35 kg, combining three active ingredients: Lamivudine, Zidovudine, and Nevirapine.
Tenofoshiv EM tablets are a combination antiretroviral therapy (ART) used for treating HIV-1 infection and for PrEP (pre-exposure prophylaxis). Key components include 300 mg Tenofovir Disoproxil Fumarate (TDF) and 200 mg Emtricitabine. It is primarily marketed for HIV treatment, managing viral load, and preventing transmission.
Oxemia 100 mg tablets contain Desidustat (100mg), an innovative oral drug used to treat anemia associated with Chronic Kidney Disease (CKD). Developed by Zydus Lifesciences, it helps improve hemoglobin levels by stimulating the body's natural production of erythropoietin.
Xovoltib 40mg Tablet is an anti-cancer medication. It works by binding and inhibiting the enzyme receptors (EGFR, HER2, and HER4) that are responsible for the growth of cancer cells. Hence, resulting in the downregulation of signaling pathways. This is how it to stop or slow the spread of cancer.
Femitraz 1 mg tablet is a medication containing Anastrozole and is primarily used for treating hormone-dependent breast cancer in postmenopausal women.
Xtane Tablet is an aromatase inhibitor. It works by lowering the amount of estrogen (a natural female hormone) produced in the body. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.
Herduo 250mg Tablet contains Lapatinib, a targeted kinase inhibitor used to treat HER2-positive advanced or metastatic breast cancer. It works by blocking epidermal growth factor receptors (HER2 and EGFR), interrupting signaling pathways that cause cancer cell growth, and promoting apoptosis. It is typically taken on an empty stomach.
Erlonat 150 mg tablet contains Erlotinib, a potent tyrosine kinase inhibitor used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the Epidermal Growth Factor Receptor (EGFR) protein, stopping cancer cell growth, and is taken once daily on an empty stomach (1 hour before or 2 hours after meals).
Clokeran 5mg Tablet is an anti-cancer medication. It works by damaging the genetic material (DNA and RNA) of the cancer cells. This stops their growth and multiplication.
Capnat 500mg Tablet is an oral chemotherapy medication containing Capecitabine, an antineoplastic agent used to treat breast, colon, rectum, and stomach cancers. It is a prodrug that is converted into 5-fluorouracil (5-FU) inside the body, which then disrupts DNA and RNA synthesis, inhibiting tumor growth and killing cancer cells.
Samitib 400 mg is a pharmaceutical tablet containing Imatinib Mesylate, which is used as a targeted therapy for various cancers and blood disorders. It functions primarily as a tyrosine kinase inhibitor.
Combinib 250 mg tablet contains Lapatinib, a targeted cancer therapy belonging to the class of kinase inhibitors. It works by dual inhibition of HER2/ErbB2 and EGFR/ErbB1 receptors, blocking growth signals to cancer cells and inducing apoptosis (programmed cell death). Primarily used for HER2-positive breast cancer, it is typically taken on an empty stomach to treat advanced or metastatic disease.
Armotraz Tablet is an aromatase inhibitor. It works by lowering the amount of estrogen (natural female hormone) produced in the body. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.
Armotraz Tablet is used alone or with other treatments, such as surgery or radiation, to treat early breast cancer in postmenopausal women.